www.springer.com
Adis is a leading global provider of drug information
Healthcare professionals, researchers, decision makers and drug developers alike rely on the information we have been providing for over 40 years through our reputable and independent portfolio of medical journals and business intelligence solutions.
News from Adis
-
EMA signs up to AdisInsight on a four-year deal
read moreThe European Medicines Agency (EMA) has signed a four-year agreement with Adis, a leading global provider of drug information, for AdisInsight, a database for drug research and development, disease treatment and decision making.
-
Double-digit growth in Impact Factors for Adis Journals
read moreThe Adis Journals team is celebrating the recent publication of the 2014 Journal Citation Reports® which revealed double-digit growth in the Impact Factor for seven of its titles over the previous year.
-
New AdisInsight platform officially launched
read moreAdis has taken a major step forward in its quest to make expertly-written drug information more accessible, with the launch of a new platform.